Pyxis Oncology, Inc. (PYXS)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
Oct 09, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology EPS Diluted (Quarterly) : -0.3961 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3961 |
| March 31, 2026 | -0.3667 |
| December 31, 2025 | -0.2888 |
| September 30, 2025 | -0.3517 |
| June 30, 2025 | -0.2964 |
| March 31, 2025 | -0.3466 |
| December 31, 2024 | -0.597 |
| September 30, 2024 | -0.3492 |
| June 30, 2024 | -0.286 |
| March 31, 2024 | -0.0635 |
| December 31, 2023 | -0.3485 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.5577 |
| June 30, 2023 | -0.4142 |
| March 31, 2023 | -0.5443 |
| December 31, 2022 | -1.033 |
| September 30, 2022 | -0.8499 |
| June 30, 2022 | -0.7877 |
| March 31, 2022 | -0.9693 |
| December 31, 2021 | -0.5223 |
| September 30, 2021 | -0.4132 |
| December 31, 2020 | -0.1335 |
| September 30, 2020 | -0.093 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.35M |
| Total Expenses (Quarterly) | 25.35M |
| Enterprise Value | 112.14M |
| Earnings Yield | -69.13% |
| Normalized Earnings Yield | -69.13 |